ATE340170T1 - S-omeprazol-magnesiumsalz - Google Patents

S-omeprazol-magnesiumsalz

Info

Publication number: ATE340170T1
Authority: AT; Austria
Prior art keywords: magnesium salt; omeprazole; omeprazole magnesium; enantiomer; solvent
Prior art date: 2002-05-17

Application number

AT03253070T

Other languages

English (en)

Inventor

Bernard Charles Sherman

Original Assignee

Bernard Charles Sherman

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-17

Filing date

2003-05-16

Publication date

2006-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29555354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE340170(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-05-16 Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman

2006-10-15 Application granted granted Critical

2006-10-15 Publication of ATE340170T1 publication Critical patent/ATE340170T1/de

Links

SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 abstract 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
229910052749 magnesium Inorganic materials 0.000 abstract 2
239000011777 magnesium Substances 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
229960000381 omeprazole Drugs 0.000 abstract 2
239000002904 solvent Substances 0.000 abstract 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
238000001704 evaporation Methods 0.000 abstract 1
-1 magnesium alkoxide Chemical class 0.000 abstract 1
159000000003 magnesium salts Chemical class 0.000 abstract 1
230000007935 neutral effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)

AT03253070T 2002-05-17 2003-05-16 S-omeprazol-magnesiumsalz ATE340170T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA2386716A CA2386716C (en)	2002-05-17	2002-05-17	Magnesium salt of s-omeprazole

Publications (1)

Publication Number	Publication Date
ATE340170T1 true ATE340170T1 (de)	2006-10-15

Family

ID=29555354

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03253070T ATE340170T1 (de)	2002-05-17	2003-05-16	S-omeprazol-magnesiumsalz

Country Status (5)

Country	Link
EP (1)	EP1375497B1 (de)
JP (1)	JP2004002422A (de)
AT (1)	ATE340170T1 (de)
CA (1)	CA2386716C (de)
DE (1)	DE60308450T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
CA2501424A1 (en)	2002-08-30	2004-03-11	Dr. Reddy's Laboratories Limited	Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
BR0315574A (pt) *	2002-10-22	2005-09-20	Ranbaxy Lab Ltd	Forma amorfa de esomeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação
WO2005082888A1 (en) *	2004-03-01	2005-09-09	Milen Merkez Ilac Endustrisi A.S.	Process for the preparation of magnesium salt of omeprazole
ES2246149B1 (es)	2004-07-02	2007-06-01	Esteve Quimica, S.A.	Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
EP1801110A1 (de)	2005-12-22	2007-06-27	KRKA, tovarna zdravil, d.d., Novo mesto	Argininsalz des Esomeprazols
EP1947099A1 (de) *	2007-01-18	2008-07-23	LEK Pharmaceuticals D.D.	Verfahren zur Entfernung von Lösungsmitteln in Omeprazol-Salzen
EP2147918A1 (de)	2008-07-21	2010-01-27	LEK Pharmaceuticals D.D.	Verfahren zur Herstellung von S-Omeprazol-Magnesium in einer stabilen Form
CN116102538B (zh) *	2023-01-29	2024-10-18	山东省分析测试中心	一种转晶制备三水合艾司奥美拉唑镁的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8301182D0 (sv) *	1983-03-04	1983-03-04	Haessle Ab	Novel compounds
SE9301830D0 (sv) *	1993-05-28	1993-05-28	Ab Astra	New compounds
SE9302396D0 (sv) *	1993-07-09	1993-07-09	Ab Astra	A novel compound form
CA2290893C (en) *	1999-11-16	2007-05-01	Bernard Charles Sherman	Magnesium omeprazole

2002
- 2002-05-17 CA CA2386716A patent/CA2386716C/en not_active Expired - Fee Related
2003
- 2003-05-16 DE DE60308450T patent/DE60308450T2/de not_active Expired - Lifetime
- 2003-05-16 EP EP03253070A patent/EP1375497B1/de not_active Revoked
- 2003-05-16 AT AT03253070T patent/ATE340170T1/de not_active IP Right Cessation
- 2003-05-19 JP JP2003140745A patent/JP2004002422A/ja active Pending

Also Published As

Publication number	Publication date
CA2386716A1 (en)	2003-11-17
EP1375497A1 (de)	2004-01-02
EP1375497B1 (de)	2006-09-20
DE60308450T2 (de)	2007-05-10
CA2386716C (en)	2012-07-24
DE60308450D1 (de)	2006-11-02
JP2004002422A (ja)	2004-01-08

Similar Documents

Publication	Publication Date	Title
JP2004506350A5 (de)	2005-03-17
ATE370956T1 (de)	2007-09-15	Metallorganisches gerüstmaterial, herstellung und verwendung
JP2006523595A5 (de)	2007-06-14
DE60308450D1 (de)	2006-11-02	S-Omeprazol-Magnesiumsalz
ATE518821T1 (de)	2011-08-15	Verfahren zur herstellung von alkenonethern
IS7909A (is)	2005-06-23	Aðferð til að framleiða ljósfræðilega hrein virk efnasambönd
ATE433434T1 (de)	2009-06-15	Verfahren zur herstellung von menthol
DE602004019472D1 (de)	2009-04-02	Herstellungsverfahren von Membran-Elektroden-Einheiten
EP1721895A4 (de)	2008-02-27	Verfahren zur herstellung von cumenhydroperoxid
DE602004021052D1 (de)	2009-06-25	Herstellungsverfahren von Xylylendiamin
DE60323456D1 (de)	2008-10-23	Herstellung von Nanopartikeln
ATE388957T1 (de)	2008-03-15	Herstellung von siliziumverbrückten metallocenverbindungen
ATE352549T1 (de)	2007-02-15	Verfahren zur herstellung von desloratadin
ATE369357T1 (de)	2007-08-15	Verfahren zur herstellung von pantoprazol und seinen salzen
ATE443709T1 (de)	2009-10-15	Verfahren zur herstellung von 9,10-dihydro-9-oxa- 10-organyl-oxyphosphaphenanthren-10-oxid oder - thion und an den phenylgruppen substituierten derivativen desselben
ATE513840T1 (de)	2011-07-15	Verfahren zur herstellung optisch aktiver diphosphane
ATE553101T1 (de)	2012-04-15	Herstellungsverfahren für 2-oxo-1-phenyl-3- oxabicycloä3.1.0ühexan
ATE412613T1 (de)	2008-11-15	Verfahren zur herstellung von aluminiumtrihydraten mit hohem porenvolumen
DE502006007059D1 (de)	2010-07-08	Racematspaltung von 2,6-trans-dimethylmorpholin
ITRM20010318A1 (it)	2002-12-09	Procedimento per la produzione di composti organici perfluorurati mediante florurazione elettrochimica.
ATE487701T1 (de)	2010-11-15	Verfahren zur herstellung von iminostilbenderivaten
ATE509998T1 (de)	2011-06-15	Verfahren zur herstellung von kerzen mit dekorativen und / oder funktionalen elementen
CY1110479T1 (el)	2015-04-29	Μια μεθοδος δια την παρασκευη μιας 10,11- διυδρο- 10- υδροξυ - 5η-διβενζ [bf] αζεπινο- 5- καρβοξυαμιδης
RU2003119992A (ru)	2004-12-27	Способ получения 1,2,3,4-тетрахлоргексафторбутана
DE602005001486D1 (de)	2007-08-09	Verfahren zur Herstellung optisch aktiver 3-Chinuclidinole

Legal Events

Date	Code	Title	Description
2007-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties